Organisms

  1. Abbo A, Navon-Venezia S, Hammer-Muntz O, et al. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 2005;11(1):22-9.
  2. Abouanaser S, Srigley J, Nguyen T, et al. Bordetella holmesii, an emerging cause of septic arthritis. J Clin Microbiol 2013;51(4):1313-5.
  3. Abreu C, Rocha-Pereira Nm Sarmento A, Magro F. Nocardia infections among immunomodulated inflammatory bowel disease patients: a review. World J Gastroenterol 2015;21(21)6491-8.
  4. Abro A, Shahmirzadi M, Jasim L, et al. Sphingobacterium multivorum bacteremia and acute meningitis in an immunocompetent adult patient: a case report. Iran Red Crescent Med J 2016;18(9):1-3.
  5. Agrawal A, Murphy TF.  Haemophilus influenzae Infections in the H. influenzae Type b Conjugate Vaccine Era.  J Clin Microbiol  2011;49(11):3728-32.
  6. Ahamed J, Gangopadhyay J, Kundu M, et al. Mechanisms of quinolone resistance in clinical isolates of Shigella dysenteriae. Antimicrob Agents Chemother 1999;43(9):2333-4.
  7. Ajmal S, Saleh O, Beam E. Development of high-grade daptomycin resistance in a patient being treated for Corynebacterium striatum infection. Antimicrob Agents Chemother 2017;61(7):1-2.
  8. Alawdah L, Campbell J, Pollock N, et al. Erysipelothrix rhusiopathiae suppurative arthritis in a 12-year-old boy after an unusual fresh water exposure. Pediatr Infect Dis J 2017;36(4):431-3.
  9. Alcaide F, Linares J, Pallares R, et al. In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother 1995;39(10):2243-7.
  10. Aldridge KE. Ertapenem (MK-0826), a new carbapenem: comparative in vitro activity against clinically significant anaerobes. Diagn Microbiol Infect Dis 2002;44(2):181-6.
  11. Aleksic D, Miletic-Drakulic S, Boskovic-Mattic T, et al. Unusual case of stroke related to Kocuria kristinae endocarditis treated with surgical procedure. Hippokratia 2016;20(3):231-4.
  12. Alfreijat M. A case of urinary tract infection and severe sepsis caused by Kluyvera ascorbata in a 73-year-old female with a brief literature review. Case Rep Infect Dis 2017;2017:3848963.
  13. Almuzara M, Barberis C, Veiga F, et al. Unusual presentations of Comamonas kerstersii infection. New Microbe New Infect 2017;19:91-5.
  14. Almuzara M, Cittadini R, Ocampo C, et al. Intra-abdominal infections due to Comomonas kerstersii. J Clin Microbiol 2013;51(6):1998-2000.
  15. Almuzara M, Limansky A, Ballerini V, et al.  In vitro susceptibility of Achromobacter spp. isolates:  comparison of disk diffusion, Etest and agar dilution methods.  Int J Antimicrob Agents 2010;35:68-71.
  16. Abouanaser S, Srigley J, Nguyen T, et al. Bordetella holmesii, an emerging cause of septic arthritis. J Clin Microbiol 2013;51(4):1313-5.
  17. Ampel N. Cefazolin for methicillin-susceptible Staphylococcus aureus bacteremia: still some questions. NEJM Infect Dis 2017.
  18. Ananthakrishna R, Shankarappa, RK, Jagadeesan N, et al.  Infective endocarditis:  a rare organism in an uncommon setting.  Case Reports Infect Dis  2012; article ID 307852.
  19. Antimicrobial susceptibility testing of Burkholderia cepacia complex (BCC) [internet]. EUCAST. 2013 Jul 19. [cited 2019 Jan 23]. Available from:  http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/General_documents/BCC_susceptibility_testing_130719.pdf
  20. Arends JE, Stemerding AM, Vorst SP, et al.  First report of a brain abscess caused by Nocardia veterana.  J Clin Microbiol 2011;49(12):4364-65.
  21. Argemi X, Hansmann Y, Riegel P, et al. Is Staphylococcus lugdunensis significant in clinical samples? J Clin Microbiol 2017;55(11):3167-74.
  22. Arias CA, Contreras GA, Murray BA.  Management of multidrug-resistant enterococcal infections.  CMI 2010;16:555-62.
  23. Ariza-Prota M, Pando-Sandoval A, Fole-Vazquez D, et al. Community-acquired bacteremic Streptomyces atratus pneumonia in an immunocompetent adult: a case report. J Med Case Rep 2015;9:262.
  24. Ataiekhorasgani M, Jafaripozve N, Zaerin O. Streptomyces infection in Cushing syndrome: a case report and literature review. Adv Biomed Res 2014;3:26.
  25. Avison MB, Bennett PM, Walsh TR. Beta-lactamase expression in Plesiomonas shigelloides. J Antimicrob Chemother 2000;45(6):877-80.
  26. Babini GS, Yuan M, Hall LM, et al. Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with extended-spectrum beta-lactamases. J Antimicrob Chemother 2003;51(3):605-12.
  27. Babu E, Oropello J.  Staphylococcus lugdunensis:  the coagulase-negative staphylococcus you don’t want to ignore.  Expert Rev Anti Infect Ther 2011;9(10):901-7
  28. Bader S, Shaikh U, Ahmed Z, et al. Prevalence and resistance pattern of Moraxella catarrhalis in community acquired lower respiratory tract infections. Infect Drug Resist 2015(8):263-7.
  29. Baig S, Hossain S, Sunderram J. A case of chronic obstructive pulmonary disease exacerbation due to Corynebacterium propinquum infection. ATS J [internet] 2017 available from https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A6048.
  30. Banzon J, Rehm S, Gordon S, et al. Propionibacterium acnes endocarditis: a case series. Clin Microbiol Infect 2017;23:396-9.
  31. Baker C, Byington CL, Polin RA.  Policy statement-recommendations for the prevention of perinatal Group B Streptococcal (GBS) disease.  Pediatrics 2011;128(3):611.
  32. Bank S, Jensen A, Hansen TM, et al.  Actinobaculum schaalii, a common uropathogen in elderly patients, Denmark.  Emerg Infect Dis 2010;16(1):76.
  33. Baqi M, Mazzulli T. Oligella infections: case report and review of the literature. Can J Infect Dis 1996;7(6):377-9.
  34. Baran I, Duzgan A, Momcuoglu I, et al. Chronic lower extremity wound infection due to Kerstersia gyiorum in a patient with Buerger’s disease: a case report. BMS Infect Dis 2017;17(1):608-15.
  35. Barnaud G, Benzerara Y, Gravisse J, et al. Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate.  Antimicrob Agents Chemother 2004;48(3):1040–2.
  36. Basaglia G, Carretto E, Barbarini D, et al. Catheter-related bacteremia due to Kocuria kristinae in a patient with ovarian cancer. J Clin Microbiol 2002;40(1):311-3.
  37. Basani L, Aepala R. Empedobacter brevis causing early onset sepsis and pneumonia in a neonate: case report and review of literature. Int J Contemp Pediatr 2018;5(2):654-6.
  38. Batra P, Mathur P, Misra M. Aeromonas spp: an emerging nosocomial pathogen. J Lab Physicians 2016;8(1):1-4.
  39. Bavbek M, Arslan C, Demirhan B, et al. Cerebral Dermabacter hominis abscess. Inf 1998;26(3):181-3.
  40. Bayram N, Devrim I, Apa H, et al. Sphingomonas paucimobilis infections in children: 24 case reports. Mediterr J Hematol Infect Dis 2013;5:1-5.
  41. Beaino M, Fares J, Malek A, et al. Sphingomonas paucimobilis-related bone and soft-tissue infections: a systematic review 2018;77:68-73.
  42. Becker K, Rutsch F, Uekotter A, et al. Kocuria rhizophila adds to the emerging spectrum of micrococcal species involved in human infections. J Clin Microbiol 2008;46(10):3537-9.
  43. Becker S, Willie T, Novo M, et al. Osteomyelitis of the middle distal phalynx caused by Arcanobacterium haemolyticum in an adolescent nail biter. Med Microbiol Rep 2017;1:1.
  44. Becker K, Wullenweber J, Odenthal HJ, et al. Prosthetic valve endocarditis due to Kytococcus schroeteri. Emerg Infect Dis 2003;9(11):1493-5.
  45. Behera B, Naik V, Mathur P, et al. Identification of Kocuria rosea by Vitek 2 GP Card. The Internet Journal of Medical Informatics 2008;3(2).
  46. Beharrysingh R. Myroides bacteremia: a case report and concise review. ID Cases 2017;8:34-6.
  47. Bellais S, Girlich D, Karim A, et al. EBR-1, a novel ambler subclass B1 β-lactamase from Empedobacter brevis. Antimicrob Agents Chemother 2002;46(10):3223-7.
  48. Bemis DA, Jones RD, Hiatt LE, et al. Comparison of tests to detect oxacillin resistance in Staphylococcus intermedius, Staphylococcus schleiferi, and Staphylococcus aureus isolates from canine hosts. J Clin Microbiol 2006;44(9):3374-6.
  49. Bernard K, Pacheco A. In vitro activity of 22 antimicrobial agents against Corynebacterium and Microbacterium species referred to the Canadian National Microbiology Laboratory. Clin Microbiol Newsl 2015;37(23):187-98.
  50. Bernard K.  The genus Corynebacterium and other medically relevant coryneform-like bacteria.  J Clin Microbiol 2012;50(10):3152-8.
  51. Best R, Bhagirath K, Pearce S, et al. Listeria monocytogenes and prosthetic valve endocarditis. Infect Dis Clin Pract 2017;1:9-12.
  52. Binder D,  Widmer U, Opravil M, et al.  Native and prosthetic valve endocarditis caused by Rothia dentocariosa: diagnostic and therapeutic considerations.  Infection 1997;25(1):22-6.
  53. Bittar F,  Cassagne C, Bosdure E, et al.  Outbreak of Corynebacterium pseudodiphtheriticum infection in cystic fibrosis patients, France.  Emerg Infect Dis 2010;16(8):1231-6.
  54. Bizarro MJ,  Callan DA, Farrel PA, et al.  Granulicatella adiacens and early-onset sepsis in neonate.  Emerg Infect Dis 2011;17(10):1971-3.
  55. Blaiotta G, Pennacchia C, Ercolini D, et al. Combining denaturing gradient gel electrophoresis of 16S rDNA V3 region and 16S-23S rDNA spacer region polymorphism analyses for the identification of staphylococci from Italian fermented sausages. Syst Appl Microbiol 2003;26(3):423-33.
  56. Blaiotta G, Pennacchia C, Villani F, et al. Diversity and dynamics of communities of coagulase-negative staphylococci in traditional fermented sausages. J Appl Microbiol 2004;97(2):271-84.
  57. Blanc V,  Dalle M, Markarian A, et al.  Gordonia terrae:  a difficult-to-diagnose emerging pathogen?  J Clin Microbiol 2007;45(3):1076-7.
  58. Blekher L, Siegman-Igra Y, Schwartz D, et al.  Clinical significance and antibiotic resistance patterns of Leminorella spp, an emerging nosocomial pathogen.  J Clin Microbiol  2000;38(8):3036-8.
  59. Bloch KC, Nadarajah R, Jacobs R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore) 1997;76(1):30-41.
  60. Blosser-Middleton R, Sahm DF, Thornsberry C, et al. Antimicrobial susceptibility of 840 clinical isolates of Haemophilus influenzae collected in four European countries in 2000-2001. Clin Microbiol Infect 2003;9(5):431-6.
  61. Bokhari S, Abbas N, Singh M, et al. Empedobacter brevis bacteremia in a patient infected with HIV: case report and review of literature. Case Rep Infect Dis 2015;2015:1-3.
  62. Boleij A, van Gelder MMHJ, Swinkels DW, et al.  Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients:  systematic review and meta-analysis.  Clin Infect Dis 2011;53(9):870-8.
  63. Bonacorsi S, Fitoussi F, Lhopital S, et al. Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 1999;43(2):213-7.
  64. Bonfiglio G, Livermore DM. Behaviour of beta-lactamase-positive and -negative Staphylococcus aureus isolates in susceptibility tests with piperacillin/tazobactam and other beta-lactam/beta-lactamase inhibitor combinations. J Antimicrob Chemother 1993;32(3):431-44.
  65. Bonfiglio G, Livermore DM. Beta-lactamase types amongst Staphylococcus aureus isolates in relation to susceptibility to beta-lactamase inhibitor combinations. J Antimicrob Chemother 1994;33(3):465-81.
  66. Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 2006;43 Suppl 2:S49-56.
  67. Bostwick A, Zhang C, Manninen K, et al. Bacteremia caused by Kerstersia gyiorum. J Clin Microbiol 2015;53(6):1965-7.
  68. Bottone EJ.  Bacillus cereus, a volatile human pathogen.  Clin Microb Rev 2010;23(2):382-98.
  69. Bourafa N, Loucif L, Boutefnouchet N, et al. Enterococcus hirae, an unusual pathogen in humans causing urinary tract infection in a patient with benign prostatic hyperplasia: first case report in Algeria. New Microbes New Infect 2015;8:7-9.
  70. Bowen A, Lilliwbridge R, Tong S, et al. Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole? J. Clin. Microbiol 2012;50(12):4067-72.
  71. Bowen C, Tong S, Andrews R, et al. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet 2014;384(9960):2132-40.
  72. Boyanton B, et al.  Burkholderia gladioli osteomyelitis in association with chronic granulomatous disease:  case report and review. Pediatr Infect Dis J 2005;24(9):837.
  73. Brazier J et al.  European surveillance study on antimicrobial susceptibility of Gram positive anaerobic cocci.  Int J Antimicrob Agents  2008;31:316-20.
  74. Brook I.  Veillonella infections in children.  J Clin Microbiol 1996;34(5):1283.
  75. Brooke JS.  Stenotrophomonas maltophilia:  an emerging global opportunistic pathogen.  Clin Microbiol Rev  2012;25(1):2.
  76. Brown WJ, Sautter RL, Crist AE Jr. Susceptibility testing of clinical isolates of Methylobacterium species. Antimicrob Agents Chemother 1992;36(8):1635-8.
  77. Brown DFJ. Regarding BORSA detection and clinical experience. Chairman, BSAC Susceptibility Testing Working Party. Health Protection Agency, Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital. In: Kulkarni S, ed. Cambridge January 2009.
  78. Brown-Elliott BA, et al.  Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.  Clin Microbiol Reviews  2006;19(2):259-82.
  79. Bruminhent J et al.  Rothia mucilaginosa prosthetic device infections:  a case of prosthetic valve endocarditis.  J Clin Microbiol  2013;51(5): 629.
  80. Buijze GA.  Serogroup C meningococcal osteomyelitis.  Pediatric Infect Dis J  2009;28(10):929.
  81. Burgess DS. Use of pharmacokinetics and pharmacodynamics to optimize antimicrobial treatment of Pseudomonas aeruginosa infections. Clin Infect Dis 2005 ;40 Suppl 2:S99-104.
  82. Buss S, Starlin R, Iwen P. Bacteremia caused by Microbacterium binotii in a patient with sickle cell anemia. J Clin Microbiol 2014;52(1):379-81.
  83. Butin, M, Rasigade JP, Subtil F, et al. Vancomycin treatment is a risk factor for vancomycin-nonsusceptible Staphylococcus capitis sepsis in preterm neonates. Clin Microbiol Infect 2017;23:839-44.
  84. Cakar M, et al.  First report of endocarditis by Alloiococcus otitidis spp in a patient with a history of chronic otitis.  J Infect Public Health  2013;6(6):494.
  85. Canas V, Ramirez M, Jimenez F, et al. Lactococcus garvieae endocarditis in a native valve identified by MALDI-TOF MS and PCR-based 16s rRNA in Spain: a case report. New Microbe New Infect 2015;5:13-15.
  86. Cargill JS, et al.  Granulicatella infection: diagnosis and management.  J Med Microbiol  2012;61:755-61.
  87. Castro C, Johnson C, Williams M, et al. Elizabethkingia anopheles: clinical experience of an academic health system in Southeastern Wisconsin. Open Forum Infect Dis 2017;4(4):1-4.
  88. Cattoir V, Guerin F. How is fosfomycin resistance developed in Escherichia coli? Future Microbiol 2018;13(16):1693-6.
  89. Cavallini F. Penicillin resistance in Streptococcus agalactiae. Abstractverwaltung AKM AG 18th European Congress of Clinical Microbiology and Infectious Disease (ECCMID) Antibacterial susceptibility studies - III April 4, 2006.
  90. Center KJ, Reboli AC, Hubler R, et al. Decreased vancomycin susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit: evidence of spread of Staphylococcus warneri. J Clin Microbiol 2003;41(10):4660-5.
  91. Cerquetti M, Giufre M, Cardines R, et al. First characterization of heterogeneous resistance to imipenem in invasive nontypeable Haemophilus influenzae isolates. Antimicrob Agents Chemother 2007;51(9):3155-61.
  92. Chagla AH, Borczyk AA, Facklam RR, et al.  Breast abscess associated with Helcococcus kunzii.  J Clin Microbiol 1998;36(8):2377-9.
  93. Chamot E, Boffi El Amari E, Rohner P, et al. Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother 2003;47(9):2756-64.
  94. Chan JFW, Woo PCY, Teng JLL, et al.  Primary infective spondylodiscitis caused by Lactococcus garvieae and a review of human L. garvieae infections.  Infection.  2011;39:259-64.
  95. Chander J, Singla N, Handa U. Human cervicofacial mycetoma caused by Streptomyces griseus: first case report. J Microbiol Immunol Infect 2015;48(6):703-5.
  96. Chang JC, Hsueh PR, Wu JJ, et al. Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother 1997;41(6):1301-6.
  97. Chang Y, Lo H. Identification, clinical aspects, susceptibility pattern, and molecular epidemiology of beta-haemolytic group G Streptococcus anginosus group isolates from central Taiwan. Diagn Microbiol. Infect. Dis 2013;76:262-5.
  98. Charles M, Berenger B, Turnbull L, et al. Variability of beta-lactam susceptibility testing for Streptococcus pneumoniae using 4 commercial test methods and broth microdilution. Diagn Microbiol Infect Dis 2016;84:240-5.
  99. Chaudhary D, Finkle SN.  Peritoneal dialysis-associated peritonitis due to Kytococcus sedentarius.  Peritoneal Dialysis International  2010;30(2):252-3.
  100. Chavan R, Pannaraj PS, Luna RA, et al.  Significant morbidity and mortality attributable to Rothia mucilaginosa infections in children with hematological malignancies or following hematopoietic stem cell transplantation.  Pediatr Hematol Oncol  2013;30(5):445-54.
  101. Chen D-Q, Song J-L, Tang H-X, et al. Extensively drug-resistant Raoultella planticola carrying multiple resistance genes including blaNDM-1. JMM Case Rep 2014;1:1-3.
  102. Chen F-L, Wang G-C, Teng S-O, et al. Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases. J Microbiol Immunol Infect 2013;46(6):425-32.
  103. Chen M, Kemp M, Bruun NE, et al.  Cardiobacterium valvarum infective endocarditis and phenotypic/molecular characterization of 11 Cardiobacterium species strains.  J Med Microbiol  2001;60:522-8.
  104. Chen X, Wang L, Zhou J, et al. Exiguobacterium sp. A1b/GX59 isolated from a patient with community-acquired pneumonia and bacteremia: genomic characterization and literature review. BMC Infect Dis 2017;17:508.
  105. Cheng AC, Currie BJ.  Meliodosis:  Epidemiology, pathophysiology, and management.  Clin Microbiol Rev 2005;18(2):383.
  106. Cheong H. Changes of clinical manifestation of Sphingomonas paucimobilis bacteremia. Open Forum Infect Dis 2017;4(1):S559.
  107. Chia J, Fend Y, Su LH, et al. Clostridium innocuum is a significant vancomycin-resistant pathogen for extraintestinal clostridial infection. Clin Microbiol Infect 2017;23:560-6.
  108. Chiquet C, Pechinot A, Creuzot-Garcher C, et al.  Acute postoperative endophthalmitis caused by Staphylococcus lugdunensis.  J Clin Microbiol 2007;45(6):1673-8.
  109. Chiron R, Marchandin H, Counil F, et al. Clinical and microbiological features of Inquilinus sp. isolates from five patients with cystic fibrosis. J Clin Microbiol 2005;43(8):3938-43.
  110. Chirurgi V, Oster S, Golberg A, et al. Ampicillin-resistant Enterococcus raffinosus in an acute-care hospital: case-control study and antimicrobial susceptibilities. J Clin Microbiol 1991;29(11):2663-5.
  111. Cho EJ, Sung H, Park SJ, et al.  Rothia mucilaginosa pneumonia diagnosed by quantitative cultures and intracellular organisms of bronchoalveolar lavage in a lymphoma patient.  Annals Laboratory Medicine  2013;33:145-9.
  112. Choksi T, Dadani F. Reviewing the emergence of Lactococcus garvieae: a case of catheter associated urinary tract infection caused by Lactococcus garvieae and Escherichia coli coinfection. Case Rep Infect Dis 2017;2017:1-4. 
  113. Chorost M, Smith N, Hutter J, et al. Bacteraemia due to Microbacterium paraoxydans in a patient with chronic kidney disease, refractory hypertension and sarcoidosis. JMM Case Rep. 2015;5:1-5.
  114. Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 1999;11(1):7-12.
  115. Christensen H, May M, Bowen L, et al.  Meningococcal carriage by age:  a systematic review and meta-analysis.  Lancet  2010;10:853-61.
  116. Christensen J, Vitko N, Voskuil M, et al. Implantable cardiac defibrillator pocket infection due to a previously undescribed Cupriavidus species. J Clin Microbiol 2010;48(7):2623-5.
  117. Chun S, Yun JW, Hun HJ, et al. Clinical characteristics of Raoultella ornithinolytica bacteremia. Infect 2015;43(1):59-64.
  118. Citro R, Prota C, Greco L, et al.  Kocuria kristinae endocarditis related to diabetic foot infection.  J Med Microbiol  2013;62(6):932-4.
  119. Citron DM, Warren YA, Fernandez HT, et al. Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens. J Clin Microbiol 2005;43(5):2485-8.
  120. Clarridge JE, Attori S, Musher DM, et al.  Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (“Streptococcus milleri Group”) are of different clinical importance and are not equally associated with abscess.  Clin Infect Dis 2001;32:1511-5.
  121. Cleve JR, Boucher BA, Smith DV, et al. Ventilator associated pneumonia caused by Raoultella ornithinolytica in two immunocompetent trauma patients. Resp Med Case Rep 2018;24:135-7.
  122. CLSI AST Subcommittee Meeting. Methods Application and Interpretation Working Group [Power Point Presentation]. CLSI 2018.
  123. Cooksey RC, Bannister ER, Farrar WE Jr. Antibiotic resistance patterns of clinical isolates of Serratia marcescens. Antimicrob Agents Chemother 1975;7(4):396-9.
  124. Cortez JMC, Imam AA, Ang JY.  Pasteurella multicoda urinary tract infection in a pediatric patient with end-stage renal disease.  Pediatric Infect Dis J 2007;26(2):183-5.
  125. Cortes-Penfield N, Kohli A, Weatherhead J, et al. Arcanobacterium haemolyticum central nervous system abscess and bacteremia following head trauma. Infect Dis Clin Pract 2017;25(3):9-11.
  126. Courvalin P, Leclercq R, Rice LB, editors.  Antibiogram.  Portland, Oregon: Eska Publishing; 2010.
  127. Crane JK, Hohman DW, Nodzo SR, et al.  Antimicrobial susceptibility of Propionibacterium acnes isolates from shoulder surgery.  Antimicrob Agents Chemother.  2013:57(7);3424-6.
  128. Currie PF, Codispoti M, Mankad PS, et al. Late aortic homograft valve endocarditis caused by Cardiobacterium hominis: a case report and review of the literature. Heart 2000;83(5):579-81.
  129. Dargere S, Vergnaud M, Verdon R, et al. Enterococcus gallinarum endocarditis occurring on native heart valves. J Clin Microbiol 2002;40(6):2308-10.
  130. Dach E, Morel CM, Murthy A, et al. Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment for methicillin-resistant Staphylococcus aureus infection: a healthcare system perspective. Clin Microbiol Infect 2017;23:659-66.
  131. De Backer E, Verhelst R, Verstraelen H, et al.  Antibiotic susceptibility of Atopobium vaginae.  BMC Infectious Diseases 2006;51(6):1-6
  132. De Champs C, Constantin JM, Bonnet R, et al. Decreased susceptibility to extended-spectrum cephalosporins of a penicillin-susceptible Streptococcus pneumoniae in meningitis. Infection 2000;28(1):58-9.
  133. Decre D, Verdet C, Emirian A, et al.  Emerging severe and fatal infections due to Klebsiella pneumoniae in two university hospitals in France.  J Clin Microbiol 2011;49(8):3012-4.
  134. De Gheldre Y, Maes N, Rost F, et al. Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance. J Clin Microbiol 1997;35(1):152-60.
  135. De Jong MFC, Soetekouw R, Reinier W, et al.  Aerococcus urinae:  severe and fatal bloodstream infections and endocarditis.  J Clin Microbiol 2010;48(9):3445-7.
  136. de la Maza L, Ruoff KL, Ferraro MJ. In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria. Antimicrob Agents Chemother 1989;33(8):1383-4.
  137. Delport J, Wakabayashi A, Anantha R, et al.  Cellulosmicrobium cellulans isolated from a patient with acute renal failure. JMM Case Rep 2014;1(2):1-4.
  138. den Hollander JG, Horrevorts AM, van Goor ML, et al. Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model. Antimicrob Agents Chemother 1997;41(1):95-100.
  139. Denham J, Nanhappa S, Greene J. Moraxella species bacteremia in cancer patients. Infect Dis Clin Pract 2018;26(4):188-90.
  140. Di Pentima MC, Mason EO Jr., Kaplan SL. In vitro antibiotic synergy against Flavobacterium meningosepticum: implications for therapeutic options. Clin Infect Dis 1998;26(5):1169-76.
  141. Dicpinigaitis P, De Aguirre M, Divito J. Enterococcus hirae bacteremia associated with acute pancreatitis and septic shock. Case Rep Infect Dis 2015;2015:1-3.
  142. Ding Y, Zhu D, Zhang J, et al. Virulence determinants, antimicrobial susceptibility, and molecular profiles of Erysipelothrix rhusiopathiae strains isolated from China. Emerg Microbes Infect 2015;4:69.
  143. Dobinson H, Anderson T, Chambers S, et al. Antimicrobial treatment options for Granulomatous mastitis caused by Corynebacterium species. J Clin Microbiol 2018;53(9):2895-9.
  144. Doern C, Burnham C. It’s not easy being green: the viridans group Streptococci, with a focus on pediatric clinical manifestations. J Clin Microbiol 2010;48(11):3829-35.
  145. Doern GV, Jones RN, Pfaller MA, et al. Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America). Diagn Microbiol Infect Dis 1999;34(1):65-72.
  146. Doern, CD, Burnham CD.  It’s not easy being green:  the Viridans Group Streptococci, with a focus on pediatric clinical manifestations.  J Clin Microbiol 2010;48(11);3829.
  147. Doran TI. The role of Citrobacter in clinical disease of children: review. Clin Infect Dis 1999;28(2):384-94.
  148. Dortet L, Legrand P, Soussy CJ, et al. Bacterial identification, clinical significance, and antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens. J Clin Microbiol 2006;44(12):4471-8.
  149. Drago L, De Vecchi E, Nicola L, et al. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin. J Antimicrob Chemother 2005;56(2):353-9.
  150. Drobniewski FA. Bacillus cereus and related species. Clin Microbiol Rev 1993;6(4):324-38.
  151. Dunn R, Bares S, David MZ.  Central venous catheter-related bacteremia caused by Kocuria kristinae:  case report and review of the literature.  Annals Clinical Microbiol Antimicrobials 2011;10:31.
  152. Eady EA, Ross JI, Cove JH, et al. Macrolide-lincosamide-streptogramin B (MLS) resistance in cutaneous propionibacteria: definition of phenotypes. J Antimicrob Chemother 1989;23(4);493-502.
  153. Eady EA, Gloor M, Leyden JJ.  Propionibacterium acnes resistance: a worldwide problem.  Dermatology 2003;206(1):54-6.
  154. Edmiston CE, Krepel CJ, Seabrook GR, et al. In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections. Antimicrob Agents Chemother 2004;48(3):1012-6.
  155. Edwards R, Greenwood D. Additional characteristics of Bacteroides fragilis carbapenemases belonging to group 3a. Antimicrob Agents Chemother 1997;41(11):2591-2.
  156. Edwards R, Hawkyard CV, Garvey MT, et al. Prevalence and degree of expression of the carbapenemase gene (cfiA) among clinical isolates of Bacteroides fragilis in Nottingham, UK. J Antimicrob Chemother 1999;43(2):273-6.
  157. Edwards M, Baker C.  Group B streptococcal infections in elderly adults.  Clin Infect Dis 2005;41:839-47.
  158. Elliott JA, Facklam RR. Antimicrobial susceptibilities of Lactococcus lactis and Lactococcus garvieae and a proposed method to discriminate between them. J Clin Microbiol 1996;34(5):1296-8.
  159. Elliott TS, Foweraker J, Gould FK, et al. Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2012;67:269-89.
  160. Elori E, Ocana R, Brusola A, et al. Tsukamurella species isolation in bronchiectasis and chronic obstructive pulmonary disease patients: a retrospective case series. Eur Resp J 2018;52(62):5312.
  161. EUCAST. EUCAST Expert Rules Version 3.1. Intrinsic Resistance and Exceptional Phenotypes Tables [Internet] 2016. Available from http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Expert_Rules/Expert_rules_intrinsic_exceptional_V3.1.pdf.
  162. EUCAST. Proposed breakpoints for Aerococcus spp. and Kingella kingae [Internet]. 2016. Available from http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Consultation/2016/Aerococcus_and_Kingella_BP_consultation_and_responses_20161212.pdf
  163. Faden H. Infections associated with Streptococcus intermedius in children. Pediatr Infect Dis. J 2016;35(9):1047-8.
  164. Falaga M, Vouloumanou E, Samonis G, et al. Fosfomycin. Clin Microbiol Rev. 2016;29(2):321-47.
  165. Fass RJ, Barnishan J, Solomon MC, et al. In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli. Antimicrob Agents Chemother 1996;40(6):1412-8.
  166. Fass RJ, Barnishan J. In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Rev Infect Dis 1980;2(6):841-53.
  167. Fefer JJ, Ratzan KR, Sharp SE, et al. Lactococcus garvieae endocarditis: report of a case and review of the literature. Diagn Microbiol Infect Dis 1998;32(2):127-30.
  168. Fernandez-Natal I, Saez-Nieto A, Medina-Pascual M, et al. Dermabacter hominis: a usually daptomycin-resistant Gram-positive organism infrequently isolated from human clinical samples. New Microbes New Infect 2013;1(3):35-40.
  169. Fields MT, Herndon BL, Bamberger DM. Beta-lactamase-mediated inactivation and efficacy of cefazolin and cefmetazole in Staphylococcus aureus abscesses. Antimicrob Agents Chemother 1993;37(2):203-6.
  170. Finegold SM, Jousimies-Somer H. Recently described clinically important anaerobic bacteria: medical aspects. Clin Infect Dis 1997;25 Suppl 2:S88-93.
  171. Finegold SM. Susceptibility testing of anaerobic bacteria. J Clin Microbiol 1988;26(7):1253-6.
  172. Fishbain J, Peleg AY.  Treatment of Acinetobacter infections.  Clin Infect Dis 2010;51(1):79-84.
  173. Fitch L, Johnson AP. Reduced susceptibility to teicoplanin in a methicillin-resistant strain of Staphylococcus aureus. J Antimicrob Chemother 1998;41(5):578.
  174. Florescu D, Hill L, Sudan D, et al.  Leuconostoc bacteremia in pediatric patients with short bowel syndrome.  Pediatr Infect Dis J 2008;27(11):1013-9.
  175. Fluegge K, Supper S, Siedler A, et al. Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany. Antimicrob Agents Chemother 2004;48(11):4444-6.
  176. Fournier B, Lagrange PH, Philippon A. In-vitro susceptibility of Klebsiella oxytoca strains to 13 beta-lactams in the presence and absence of beta-lactamase inhibitors. J Antimicrob Chemother 1996;37(5):931-42.
  177. Frank KL, del Pozo J, Patel R.  From clinical microbiology to infection pathogenesis:  how daring to be different works for Staphylococcus lugdunensis.  Clinical Microbiol Rev 2008;21(1):111-33.
  178. Fraser SL, Jorgensen JH. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother 1997;41(12):2738-41.
  179. Fujita A, Kimura K, Yokoyama S, et al. Characterization of piperacillin/tazobactam resistant Klebsiella oxytoca recovered from a nosocomial outbreak. PLoS One 2015;10(11);1-11.
  180. Fung, Pui-Man. Streptococcus bovis endocarditis with vertebral osteomyletis, spondylodiscitis, meningitis and colonic carcinoma in 72-year-old man presenting with neck pain. J Hong Kong Geriatrics Society 1997;8(1).
  181. Funke G, Frodl R, Spommer H.  First comprehensively documented case of Paracoccus yeei infection in a human.  J Clin Microbiol 2004;42(7):3366-8.
  182. Furuya R, Onoye Y, Kanayama A, et al.  Antimicrobial resistance in clinical isolates of Neisseria subflava from the oral cavities of a Japanese population.  J Infect Chemother 2007;13:302-4.
  183. Gales AC, Jones RN, Andrade SS, et al. Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002). Mem Inst Oswaldo Cruz 2005;100(6):571-7.
  184. Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 2001;39(1):183-90.
  185. Gallay A, Prouzet-Mauleon V, Kempf I, et al. Campylobacter antimicrobial drug resistance among humans, broiler chickens, and pigs, France. Emerg Infect Dis 2007;13(2):259-66.
  186. Galperine T, Cazorla C, Blanchard E, et al Streptococcus canis infections in humans: retrospective study of 54 patients.  J infect 2007;55(1):23-6.
  187. Gandhi R. Neisseria meningitides as a urogenital pathogen. NEJM Infect Dis 2017;20(6)2.
  188. Garcia-Granja P. Infective endocarditis due to Listeria monocytogenes: a report of 4 patients. Rev Esp Cardiol 2016;69(7):699-709.
  189. Garcia-Solache M, Rice L. The Enterococcus: a model of adaptability to its environment. Clin Microbiol Rev 2019;32(2):1-28.
  190. Gardiner B, Mahony A, Ellis A, et al. Is fosfomycin a potential treatment alternative for multi-drug resistant Gram-negative prostatitis? Clin Infect Dis 2014;58(4):101-5.
  191. Gasch O, Fernández N, Armisen A, et al.  Community-acquired Capnocytophaga canimorsus meningitis in adults:  report of one case with a subacute course and deafness, and literature review.  Enferm Infecc Microbiol Clin 2009;27(1):33-6.
  192. Gavalda J, Len O, Miro JM, et al.  Brief communication:  treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.  Annals Intern Med 2007;146:574-9.
  193. Gelfand M, Cleveland K, Ketterer D. Susceptibility of Streptococcus pyogenes to trimethoprim-sulfamethoxazole. J Clin Microbiol 2013;51(4):1350.
  194. Gelfand, M. Treatment, prognosis, and prevention of Listeria monocytogenes infection. Uptodate[internet]2019. Available from https://www.uptodate.com/contents/treatment-prognosis-and-prevention-of-listeria-monocytogenes-infection?search=treatment,%20prognosis%20and%20prevention%20of%20listeria%20monocytogene&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
  195. Gerber J, Glas M, Frank G, et al.  Streptococcus bovis infection in young infants.  Pediatr Infect Dis J 2006;25(11):1069-73.
  196. German GJ, Jamieson FB, Gilmour M, et al. Interim recommendations for the reporting of extensively drug resistant and pan-drug resistant isolates of Enterobacteriacae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia. CCDR 20167;42(4):91-7.
  197. Gilarranz R, Chamizo F, Horcajada I, et al. Prosthetic joint infection caused by Trueperella bernardiae. J Infect Chemother 2016;22:642-4.
  198. Girlich D, Naas T, Bellais S, et al. Biochemical-genetic characterization and regulation of expression of an ACC-1-like chromosome-borne cephalosporinase from Hafnia alvei. Antimicrob Agents Chemother 2000;44(6):1470-8.
  199. Gilbert DN, Moellering Jr.  RC, Eliopoulos GM, et al. The Sanford Guide to Antimicrobial Therapy, 2014. Sperryville, VA.: Antimicrobial Therapy Inc. 2014.
  200. Godreuil S, Jean-Pierre H, Morel J. Unusual case of spondylodiscitis due to Staphylococcus saccharolyticus. Joint Bone Spine 2005;72:89-97.
  201. Goldstein EJC, Citron DM.  Resistance trends in antimicrobial susceptibility of anaerobic bacteria part I.  CM Newsletter 2011;33(1):1-8.
  202. Goldstein EJC, Citron DM.  Resistance trends in antimicrobial susceptibility of anaerobic bacteria part II.  CM Newsletter 2011;33(2):9-15.
  203. Goldstein EJ, Citron DM, Merriam CV, et al. In vitro activities of daptomycin, vancomycin, quinupristin-dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates. Antimicrob Agents Chemother 2003;47(1):337-41.
  204. Goldstein E, Tyrrell K, Citron D. Lactobacillus species: taxonomic complexity and controversial susceptibilities. Clin Infect Dis 2016;60(2):98-107.
  205. Gomez E, Gustafson DR, Rosenblatt JE, et al.  Actinobaculum bacteremia:  a report of 12 cases.  J Clin Microbiol 2011;49(12):4311-3.
  206. Gomez-Garces J, Oteo J, Garcia G, et al. Bacteremia by Dermabacter hominis, a rare pathogen. J Clin Microbiol 2001;39(6):2356-7.
  207. Gonzalez A, Jennings E, Vazirir S, et al. Second report of Nocardia beijingensis infections in the United States: nodular scleritis with in vitro imipenem resistance. Digit J Opthamol 2016;22:62-5.
  208. Gowe I, Parsons C, Best M, et al. Successful treatment of olecranon bursitis caused by Trueperella bernardiae: importance of environmental exposure and pathogen identification. Case Rep Infect Dis 2018;2018:1-4.
  209. Goyache J, Vela AI, Gibello A, et al. Lactococcus lactis subsp. lactis infection in waterfowl: first confirmation in animals. Emerg Infect Dis 2001;7(5):884-6.
  210. Grady E, MacDonald J, Liu L, et al. Current knowledge and perspectives on Paenibacillus: a review. Microb Cell Fact 2016;15:1-18.
  211. Graham JC, Gould FK. Role of aminoglycosides in the treatment of bacterial endocarditis. J Antimicrob Chemother 2002;49(3):437-44.
  212. Gravey F, Jacquier H, Le Monnier Al, et al. Clinical Significance and antimicrobial susceptibility of emerging uropathogens Aerococcus urinae, Aerococcus sanguinicola and Actinotignum schaalii: a multicentre prospective study. 27th ECCMID: The Congress of ESCMID 2017.
  213. Grayson ML.  Kucers’ the use of antibiotics 6th Edition, Volume 1.  Great Britain: Hodder Arnold; 2010.
  214. Guglielmo BJ, Luber AD, Paletta D Jr., et al. Ceftriaxone therapy for staphylococcal osteomyelitis: a review. Clin Infect Dis 2000;30(1):205-7.
  215. Gupta A, Logan J, Elhag N, et al. Sphingobacterium spiritivorum infection in a patient with end stage renal disease on haemodialysis. Ann Clin Mirobiol Antimicrob 2015;15:1-4.
  216. Gustavsson O, Johansson A, Monstein H-J, et al. A wide spectrum of fastidious and ampicillin-susceptible bacteria dominate in animal-caused wounds. Eur J Clin Microbiol Infect Dis 2016;35:1315-21.
  217. Hagiya H, Ohnishi K, Maki M, et al. Clinical characteristics of Ochrobactrum anthropic bacteremia. J Clin Microbiol 2013;51(4):1330-3.
  218. Hajjar R, Schwenter F, Su S-H, et al. Community-acquired infection to Raoultella ornithinolytica presenting as appendicitis and shock in a healthy individual. J Surg Case Rep 2018;5:1-3.
  219. Han F, Walker R, Janes M, et al. Antimicrobial susceptibilities of Vibrio parahaemolyticus and Vibrio vulnificus isolates from Louisiana Gulf and retail raw oysters. Appl Environ Microbiol 2007;73(21):7096-8.
  220. Han M-S, Kim H, Lee Y, et al. Relative prevalence and antimicrobial susceptibility of clinical isolates of Elizabethkingia species based on 16S rRNA gene sequencing. J Clin Microbiol 2017;55(1):274-80.
  221. Han XY, Meltzer MC, Woods JT, et al.  Endocarditis with ruptured cerebral aneurysm caused by Cardiobacterium valvarum sp. nov.  J Clin Microbiol 2004;42(4):1590-5.
  222. Hanslik T, Hartig C, Jurand C, et al. Clinical significance of tolerant strains of streptococci in adults with infective endocarditis. Clin Microbiol Infect 2003;9(8):852-7.
  223. Harris JB, LaRocque RC, Qadri F, et al.  Cholera.  Lancet.  2012;379:2466-76.
  224. Harris P, Tambyah P, Lye D, et al. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance. A randomized clinical trial. JAMA 2018;320(10):984-94.
  225. Hashavya S, Averbuch D, Berger I, et al. Neonatal sepsis following maternal amnionitis by Edwardsiella tarda: a case report and a review of the literature. Eur J Pediatr 2011;170:111-3.
  226. Hassan S, Amer S, Mittal C, et al. Ewingella americana: an emerging true pathogen. Case Rep Infect Dis 2012.
  227. Hassan S, Amer S, Mittal C, et al.  Ewingella americana:  an emerging true pathogen.  Case Reports Infect Dis; Volume 2012, Article ID 730720, 2 pages.
  228. Hatch S, Sree A, Tirrell S, et al.  Metastatic complications from Staphylococcus intermedius, a zoonotic pathogen.  J Clin Microbiol 2012;50(3):1099.
  229. Hayden M, Won S. Carbapenem-sparing therapy for extended-spectrum beta-lactamase-producing E coli and Klebsiella pneumoniae bloodstream infection. The search continues. JAMA 2018;320(10):979-81.
  230. Hery-Arnaud G, Doloy A, Ansart S, et al.  Globicatella sanguinis meningitis associated with human carriage.  J Clin Microbiol 2010;48(4):1491.
  231. Hess B, Burtchett A, Huntington MK.  Leclercia adecarboxylata in an immunocompetent patient.  J Med Microbiol 2008;57:896-8.
  232. Hibi A, Kumano Y. Sphingobacterium spiritivorum bacteremia due to cellulitis in an elderly man with chronic obstructive pulmonary disease and congestive heart failure: a case report. J Med Case Rep 2017;11(1-5).
  233. Higashide T, Takahashi M, Kobayashi A, et al. Endophthalmitis caused by Enterococcus mundtii. J Clin Microbiol 2005;43(3):1475-6.
  234. Higgins PG, Wisplinghoff H, Stefanik D, et al. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother 2004;48(5):1586-92.
  235. Hilf M, Yu VL, Sharp J, et al. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 1989;87(5):540-6.
  236. Hilliard NJ, Schelonka RL, Waites KB. Bacillus cereus bacteremia in a preterm neonate. J Clin Microbiol 2003;41(7):3441-4.
  237. Hindler FJ. Non-Enterobacteriaceae: the latest on susceptibility testing (588-971-08). San Francisco, USA: 2008 Teleconference Series APHL, Clinical And Laboratory Standards Institute 2008.
  238. Hironaga M, Yamane K, Inaba M, et al.  Characterization and antimicrobial susceptibility of Dysgonomonas capnocytophagoides isolated from human blood sample.  J Infect Dis 2008;61:212-3.
  239. Banno H,  Kimura K, Tanaka Y, et al.  Characterization of multidrug-resistant Group B streptococci with reduced penicillin susceptibility forming small non-beta-hemolytic colonies on sheep blood agar plates.  J Clin Microbiol 2014;52(6):2169-71.
  240. Hocqueloux L, Poisson DM, Sunder S, et al.  Septic arthritis caused by Erysipelothrix rhusiopathiae in a prosthetic knee joint.  J Clin Microbiol 2010;48(1):333-5.
  241. Hoenigl M, Leitner E, Valentin T, et al.  Endocarditis caused by Actinobaculum schaalii, Austria.  Emerg Infect Dis 2010;16(7):1170-3.
  242. Hofseth K, Dalen H, Kibsgaard L, et al. Infectious tenosynovitis with bloodstream infection caused by Erysipelothrix rhusiopathiae, a case report on an occupational pathogen. BMC Infect Dis 2017;17(1):12.
  243. Holt HM, Gahrn-Hansen B, Bruun B.  Shewanella algae and Shewanella putrefaciens:  clinical and microbiological characteristics.  Clin Microbiol Infect 2005;11:347-52.
  244. Holzmann D, Funke G, Linder T, et al. Turicella otitidis and Corynebacterium auris do not cause otitis media with effusion in children. Pediatr Infect Dis J 2002;21:1124-6.
  245. Hong E, Deghmane A-E, Taha M-K. Acquisition of beta-lactamase by Neisseria meningitides through possible horizontal gene transfer. Antimicrob Agents Chemother 2018;62(9):1-3.
  246. Horino T, Shimamura Y, Ogata K, et al. Kocuria kristinae septic arthritis associated with infectious endocarditis in a hemodialysis patient with diabetes mellitus: a case report and literature review. Ren Replace Ther 2016;2:1-9.
  247. Horita N, Shibata Y, Watanabe H, et al. Comparison of antipseudomonal beta-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis. Clin Microbiol Infect 2017;23:723-9.
  248. Horton L, Mehta S, Aganovic L, et al. Actinotignum schaalii infection: a clandestine cause of sterile pyuria? Open forum Infect dis 2018;5(2);1-3.
  249. Hsueh PR, Teng LJ, Yang PC, et al. Susceptibilities of Chryseobacterium indologenes and Chryseobacterium meningosepticum to cefepime and cefpirome. J Clin Microbiol 1997;35(12):3323-4.
  250. Hsueh PR, Teng LJ, Lee LN, et al. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob Agents Chemother 2001;45(11):3205-8.
  251. Humphries RM, Lee C, Hindler JA.  Aerococcus urinae and trimethoprim-sulfamethoxazole.  J Clin Microbiol 2011;49(11):3934-5.
  252. Humphries RM, Hindler JA.  In vitro antimicrobial susceptibility of Aerococcus urinae.  J Clin Microbiol 2014;52(6):2177.
  253. Humphries R, Pollett S, Sakoulas G. A current perspective on Daptomycin for the clinical microbiologist. Clin Microbiol Rev 2013;26(4):759-80.
  254. Hu J, Robinson JL.  Systematic review of invasive Acinetobacter Infections in children.  Can J Infect Dis Med Microbiol, 2010;21(2):83.
  255. Hung KH, Wang MC, Huang AH, et al.  Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii.  J Clin Microbiol 2012;50(3):721-6.
  256. Huse H, Miller S, Chandrasekaran S, et al. Evaluation of oxacillin and cefoxitin disk diffusion and MIC breakpoints established by the Clinical and Laboratory Standards institute for detection of mecA-mediated oxacillin resistance in Staphylococcus schleiferi. J Clin Microbiol 2018;56(2):1-10.
  257. Ikeda M, Yagihara Y, Tatsuna K, et al. Clinical characteristics and antimicrobial susceptibility of Bacillus cereus blood stream infections. Ann Clin Microbiol Antimicrob 2015;14:43.
  258. Islam M, Midzi S, Charimari L, et al. Susceptibility to fluoroquinolones of Vibrio cholera 01 isolated from diarrheal patients in Zimbabwe. JAMA 2009;302(21):2321-2
  259. Iversen C, Lehner A, Mullane N, et al. Identification of "Cronobacter" spp. (Enterobacter sakazakii). J Clin Microbiol 2007;45(11):3814-6.
  260. Iversen C, Lehner A, Mullane N, et al. The taxonomy of Enterobacter sakazakii: proposal of a new genus Cronobacter gen. nov. and descriptions of Cronobacter sakazakii comb. nov. Cronobacter sakazakii subsp. sakazakii, comb. nov., Cronobacter sakazakii subsp. malonaticus subsp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov. and Cronobacter genomospecies 1. BMC Evol Biol 2007;7:64.
  261. Iwen P, Mindru C, Kalil AC, et al.  Pediococcus acidilactici endocarditis successfully treated with daptomycin.  J Clin Microbiol 2012;50(3):1106-8.
  262. James W. Arcanobacterium haemolyticum: background, pathophysiology, epidemiology. Medscape [internet] 2017. Available from: https://emedicine.medscape.com/article/1054547-overview.
  263. Jampala S, Meera P, Vivek V, et al. Skin and soft tissue infections due to Shewanella algae – an emerging pathogen. J Clin Diag Res 2015;9(2):16-20.
  264. Janda WM.  Update on the HACEK group of fastidious Gram-negative bacilli, part I.  Clin Microbiol Newsletter 2013;35(11):87-93.
  265. Janda WM.  Update on the HACEK group of fastidious Gram-negative bacilli, part II.  Clin Microbiol Newsletter 2013;35(12):95-101.
  266. Janda J.M, Abbott SL.  The genus Aeromonas:  taxonomy, pathogenicity, and infection.  J Clin Microbiol 2010;23(1):35-73.
  267. Janda JM, Abbott SL.  The genus Hafnia:  from soup to nuts.  J Clin Microbiol 2006;19(1):12-28.
  268. Jannat-Khah DP, Halsey ES, Lasker BA, et al.  Gordonia araii infection associated with an orthopedic device and review of the literature on medical device-associated Gordonia infections.  J Clin Microbiol 2009;47(2):499-502.
  269. Jiang JH, Dexter C, Cameron D, et al. Evolution of daptomycin resistance in coagulase-negative Staphylococci involves mutations of the essential two-component regulator walKR. Antimicrob Agents Chemother 2019;63(3).
  270. Johnson DM, Biedenbach DJ, Jones RN. Potency and antimicrobial spectrum update for piperacillin/tazobactam (2000): emphasis on its activity against resistant organism populations and generally untested species causing community-acquired respiratory tract infections. Diagn Microbiol Infect Dis 2002;43(1):49-60.
  271. Johnson PDR, et al.  A sustained hospital outbreak of vancomycin- resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203.  J Infect Dis 2010;202:1278.
  272. Jones ME, Karlowsky JA, Draghi DC, et al. Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy. Int J Antimicrob Agents 2004;23(3):240-6.
  273. Jones RN, Sader HS, Beach ML. Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains of non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001). Int J Antimicrob Agents 2003;22(6):551-6.
  274. Jones RN, Stilwell MG, Hogan PA, et al. Activity of linezolid against 3,251 strains of uncommonly isolated gram-positive organisms: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 2007;51(4):1491-3.
  275. Jorgensen JH, Crawford SA, Fiebelkorn KR. Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents. J Clin Microbiol 2005;43(7):3162-71.
  276. Jourdain S, Miendje Deyi VY, Musampa K, et al. Kytococcus schroeteri infection of a ventriculoperitoneal shunt in a child. Int J Infect Dis 2009;13(4):e153-5.
  277. Junckerstorff R, Murray R. Streptococcus anginosus group bacteria: no longer a case of mistaken identity. Clin Microbiol Newsl 2016;38(5):35-40.
  278. Kanafani Z. Invasive Cutibacterium (formerly Propionibacterium) infections. Up to Date [Internet] 2017. Available from: https://www.uptodate.com/contents/invasive-cutibacterium-formerly-propionibacterium-infections
  279. Kandi V, Palange P, Vaish R, et al. Emerging bacterial infection: Identification and clinical significance of Kocuria species. Cureus 2016;731:1-6.
  280. Kaniyarakkal V, Orvankundil S, Lalitha S, et al. Chromobacterium violaceum septicaemia and urinary tract infection: case reports from a tertiary care hospital in South India. Case Rep Infect Dis 2016:1-4.
  281. Karlowsky JA, Jones ME, Draghi DC, et al. Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime. Antimicrob Agents Chemother 2003;47(10):3155-60.
  282. Kati C, Bibashi E, Kokolina E, et al.  Case of peritonitis caused by Ewingella americana in a patient undergoing continuous ambulatory peritoneal dialysis.  J Clin Microbiol 1999;37(11):3733-4.
  283. Keikha M. Williamsia spp. are emerging opportunistic bacteria. New Microbes New Infect 2018;21:88-9.
  284. Kernodle DS, Classen DC, Stratton CW, et al. Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections. J Clin Microbiol 1998;36(1):219-22.
  285. Kieffer N, Nordmann P, Poirel L. Moraxella species as potential sources of MCR-like polymyxin resistance determinants. Antimicrob Agents Chemother 2017;61(6):1-7.
  286. Kim JS, Lee TW, Ihm CG, et al. CAPD peritonitis caused by co-infection with Cellulosmicrobium cellulans (Oerskovia xanthineolytica) and Enterobacter cloacae. A case report and literature review. Intern Med 2015;54(6):627-30.
  287. Kim KY, Cho JH, Yu CM, et al. A case of community-acquired bacteremic empyema caused by Kocuria kristinae. Infect Chemother 2018;50(2);144-8.
  288. Kim Y, Moon J, Song K, et al. Two cases of bacteremia due to Roseomonas mucosa. Ann Lab Med 2016;36(4):367-70.
  289. Kimura K, Suzuki S, Wachino J, et al. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 2008;52(8):2890-7.
  290. Kirby JT, Sader HS, Walsh TR, et al. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001). J Clin Microbiol 2004;42(1):445-8.
  291. Kitamura Y, Sawabe E, Ohkusu K, et al.  First report of sepsis caused by Rhodococcus corynebacterioides in a patient with myelodysplastic syndrome.  J Clin Microbiol 2012;50(3):1089-91.
  292. Klotchko A, Wallace MR, Licitra M, et al.  Staphylococcus lugdunensis:  an emerging pathogen.  Southern Med J 2011;104(7):509.
  293. Ko, JH, Kang CI, Cornejo-Juarez P, et al. Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis. Clin Microbiol Infect, forthcoming 2018.
  294. Kobayashi T, Nakamura I, Fujita H, et al. First case report of infection due to Cupriavidus gilardii in a patient without immunodeficiency: a case report. BMC Infect Dis 2016;16(493):1-4.
  295. Kolikonda M, Jayakumar P, Siriamula S, et al. Kocuria kristinae infection during adalimumab treatment. 2017;129(2):296-8.
  296. Kononen E, Wade W. Actinomyces and related organisms in human infections. Clin Microbiol Rev 2015;28(2):419-42.
  297. Koufakis T, Chatzopoulou M, Margaritis A, et al. Pneumonia by Listeria monocytogenes: a common infection by an uncommon pathogen. Case Rep Infect Dis 2015;2015:1-3.
  298. Kovaleva J, Degener JE, van der Mei HC, et al.  Methylobacterium and its role in health care-associated infection.  J Clin Microbiol 2014;52(5):1317-20.
  299. Kuo SC, Chen PC, Shiau YR, et al.  Levofloxacin-resistant Haemophilus influenza, Taiwan, 2004-2010.  Emerg Infect Dis 2014; 20(8):1386-90. 
  300. Frank KL, del Pozo JL, Patel R.  From clinical microbiology to infection pathogenesis:  how daring to be different works for Staphylococcus lugdunensis.  Clin Microbiol Rev 2008;Jan:111-33.
  301. Kuo IC, Lu PL, Lin WR, et al.  Sphingomonas paucimobilis bacteraemia and septic arthritis in a diabetic patient presenting with septic pulmonary emboli.  J Med Microbiol 2009;58(9):1259-63.
  302. LaClaire L, Facklam R. Antimicrobial susceptibilities and clinical sources of Facklamia species. Antimicrob Agents Chemother 2000;44(8):2130-2.
  303. Laclaire L, Facklam R. Antimicrobial susceptibility and clinical sources of Dolosigranulum pigrum cultures. Antimicrob Agents Chemother 2000;44(7):2001-3.
  304. Lai CC, Wang JY, Lin SH, et al.  Catheter-related bacteraemia and infective endocarditis caused by Kocuria species.  Clin Microbiol Infect 2011;17(2):190-2.
  305. Lai CC, Cheng A, Liu WL, et al.  Infections caused by unusual Methylobacterium species.  J Clin Microbiol 2011;49(9):3329-31.
  306. Lainhart W, Yarbough M, Burnham CA. The brief case: Staphylococcus intermedius group – look what the dog dragged in. J Clin Microbiol 2018;56(2):1-5.
  307. Lam J, Wu A, Leung W, et al. Gordonia species as emerging causes of continuous-ambulatory-peritoneal-dialysis-related peritonitis identified by 16S rRNA and secA1 gene sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALTI-TOF MS). J Clin Micobiol 2015;53(2):671-6.
  308. Lam P, Naimark D, Leis J. Microbacterium peritonitis in peritoneal dialysis: a case report and review. Perit Dial Int 2018;38(1):9-13.
  309. Lam P, Tadros M, Fong I. Mandibular osteomyelitisdue to Raoultella species. JMM Case Rep 2018;5:1-3.
  310. Lawrence C, Waseem S, Newsholme W, et al. Trueperella bernardiae: an unusual case of septic thrombophlebitis in an injection drug user. New Microbes New Infect 2018;26:89-91.
  311. Lawson PA, Malnick H, Collins MD, et al. Description of Kingella potus sp. nov., an organism isolated from a wound caused by an animal bite. J Clin Microbiol 2005;43(7):3526-9.
  312. Lawson PA, Carlson P, Wernersson S, et al.  Dysgonomonas hofstadii sp. nov., isolated from a human clinical source.  Anaerobe 2010;16(2):161-4.
  313. Le Brun C, Bouet J, Gautier P, et al. Kytococcus schroeteri endocarditis. Emerg Infect Dis 2005;11(1):179-80.
  314. Ledina D, Ivic I, Karanovic J, et al.  Campylobacter fetus infection presenting with bacteremia and cellulitis in a 72-year-old man with an implanted pacemaker: a case report.  J Med Case Reports 2012;6:414.
  315. Lee CC, Chen PL, Wang LR, et al.  Fatal cause of community-acquired bacteremia and necrotizing fasciitis caused by Chryseobacterium meningosepticum:  case report and review of the literature.  J Clin Microbiol 2006;44(3):1181-3.
  316. Lee HJ, Cho CH, Kwon MJ, et al. A patient with fatal septicemia caused by a rare pathogen Dermabacter hominis. Infect Chemother 2011;43(1):86-8.
  317. Lee MR, Huang YT, Liao CH, et al.  Clinical and microbiological characteristics of bacteremia caused by Eggerthella, Paraeggerthella, and Eubacterium species at a university hospital in Taiwan from 2001 to 2010.  J Clin Microbiol 2012;50(6):2053-5.
  318. Lee S, Kwon KT, Kim HI, et al. Clinical implications of cefazolin inoculum effect and beta-lactamase type of methicillin-susceptible Staphylococcus aureus bacteremia. Microb Drug Resist 2014;20(6):568-74.
  319. Lee S, Song KH, Jung SI, et al. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteremia: a prospective multicentre cohort study in Korea. Clin Microbiol Infect 2018;24:152-8.
  320. Legat FJ, Krause R, Zenahlik P, et al. Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection. Antimicrob Agents Chemother 2005;49(10):4368-71.
  321. Leibovici L, Paul M, Poznanski O, et al. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother 1997;41(5):1127-33.
  322. Leung D, Davis EM, Qian Q, et al.  First report of prosthetic joint infection by Gemella sanguinis and associated “pseudosatelliting” phenomenon on culture.  J Clin Microbiol 2011;49(9):3395-7.
  323. Levenga H, Donnelly P,  Blijlevens N, et al.  Fatal hemorrhagic pneumonia caused by infection due to Kytococcus sedentarius – a pathogen or passenger?  Ann Hematol 2004;83(7):447-9.
  324. Liassine N, Madec S, Ninet B, et al. Postneurosurgical meningitis due to Proteus penneri with selection of a ceftriaxone-resistant isolate: analysis of chromosomal class A beta-lactamase HugA and its LysR-type regulatory protein HugR. Antimicrob Agents Chemother 2002;46(1):216-9.
  325. Licker M, Sorescu T, Rus M, et al. Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients. Infect Drug Resist 2018;11:743-9.
  326. Liderot K, Larsson M, Borang S, et al.  Polymicrobial bloodstream infection with Eggerthella lenta and Desulfovibrio desulfuricans.  J Clin Microbiol 2010;48(10):3810-2.
  327. Lim C, Lee S. A rare case of Ralstonia mannitolilytica infection in an end stage renal patient on maintenance dialysis during municipal water contamination. Pak J Med Sci 2017;33(4):1047-9.
  328. Limelette A, Giusti D, Anuset D, et al. Amoxicillin-tolerant Pasteurella multocida strain isolated from chronic dermohypodermitis after suboptimal exposure to amoxicillin is not associated with reduced growth rate. J Med Microbiol 2018;67(4):579-84.
  329. Lin J-N, Lai C-H, Yang C-H, et al. Comparison of clinical manifestations, antimicrobial susceptibility patterns, and mutations of fluoroquinolone target genes between Elizabethkingia meningoseptica and Elizabethkingia anopheles isolated in Taiwan. J Clin Med 2018;7(538):1-12.
  330. Lin WR, et al.  Cellulitis and bacteremia caused by Bergeyella zoohelcum.  J Formos Med Assoc 2007;106(70):573-6.
  331. Lin Y, Majumdar S, Hennessy J, et al. The spectrum of Chromobacterium violaceum infections from a single geographic location. Am J Trop Med Hyg 2016;94(4):710-16.
  332. LiPuma J. Update on Burkholderia nomenclature and resistance. Clin Microbiol Newsletter 2007;29(9):65-9.
  333. Livermore DM, Winstanley TG, Shannon KP. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes.  J Antimicrob Chemother 2001;48 Suppl 1:87-102.
  334. Livorsi D, Crispell E, Satola S, et al. Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 2012;56(8):4474-7.
  335. Looney WJ, Narita M, Muhlemann K, et al.  Stenotrophomonas maltophilia:  an emerging opportunist human pathogen.  Lancet Infect Dis 2009;9:312-3.
  336. Lorenzin G, Piccinelli G, Carlassara L, et al. Myroides odoratimimus urinary tract infection in an immunocompromised patient: an emerging multidrug-resistant micro-organism. Antimicrob Resist Inf Control 2018;7:1-6.
  337. Lotte L, Lotte R, Durand M, et al. Infections related to Actinotignum schaalii (formerly Actinobaculum schaali): a 3-year prospective observational study on 50 cases. Clin Microbiol Infect 2016;22(4):388-90.
  338. Loubet P, Burdet C, Vindrios W, et al. Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a narrative review. Clin Microbiol Infect 2018;24(2):125-32.
  339. Lucarelli C, Domenico E, Toma L, et al. Ralstonia mannitolytica infections in an oncologic day ward: description of a cluster among high-risk patients. Antimicrob Resist Infect Contr 2017;6(20):1-7.
  340. Luna VA, King DS, Gulledge J, et al.  Susceptibility of Bacillus anthracis, Bacillus cereus, Bacillus mycoides, Bacillus pseudomycoides and Bacillus thuringiensis to 24 antimicrobials using sensititre automated microbroth dilution and Etest agar gradient diffusion methods.  J Antimicrob Chemother 2007;60:555-67.
  341. Ma ES, Wong CL, Lai KT, et al. Kocuria kristinae infection associated with acute cholecystitis. BMC Infect Dis 2005;5(1):60.
  342. Ma G, Wu G, Wang H, et al. Characterization of ciprofloxacin resistance in laboratory derived mutants of Vibrio parahaemolyticus with qnr gene. Foodborne Pathog Dis 2018;15(11):711-7.
  343. Malkan A, Strollo W, Scholand S, et al. Implanted-port-catheter-related sepsis caused by Acidovorax avenae and methicillin-sensitive Staphylococcus aureus. J Clin Microbiol 2009;47(10):3558-61.
  344. Maluping RP, Lavilla-Pitogo CR, DePaola A, et al. Antimicrobial susceptibility of Aeromonas spp., Vibrio spp. and Plesiomonas shigelloides isolated in the Philippines and Thailand. Int J Antimicrob Agents 2005;25(4):348-50.
  345. Manchanda V, Bhalla P. Emergence of non-ceftriaxone-susceptible Neisseria meningitidis in India. J Clin Microbiol 2006;44(11):4290-1.
  346. Maragakis LL, Perl TM.  Acinetobacter baumannii:  epidemiology, antimicrobial resistance, and treatment options.  Clin Infect Dis 2008;46:1254-63.
  347. Marbjerg L, Gaini S, Justesen U. First report of Sphingomonas koreensis as a human pathogen in a patient with meningitis. J Clin Microbiol 2015;53(3):1028-30.
  348. Marcelin J, Tan E, Adeel N, et al. Erysipelothrix rhusiopathiae bloodstream infection: a 22-year experience at Mayo Clinic, Minnesota. Open Forum Infect Dis 2016;3(1):1098.
  349. Marriott D, Stark D, Harkness J, et al.  Veillonella parvula discitis and secondary bacteremia:  a rare infection complicating endoscopy and colonoscopy?  J Clin Microbiol 2007;45(2):672-4.
  350. Martin J, Bemer P, Touchais S, et al. Recurrent abscesses due to Finegoldia magna, Dermabacter hominis and Staphylococcus aureus in an immunocompetent patient. Anaerobe 2009;15(5):201-3.
  351. Martina P, Martinez M, Frada G, et al. First time identification of Pandoraea sputorum from a patient with cystic fibrosis in Argentina: a case report. BMC Pulm Med 2017;17:1-5.
  352. Martinez E, Miro JM, Almirante B, et al. Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults. Clin Infect Dis 2002;35(2):130-9.
  353. Matar GM, Cuzon G, Araj GF, et al. Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon. Clin Microbiol Infect 2008;14(9):887-8.
  354. Mattoo S, Cherry JD.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.  Clin Microbiol Reviews 2005;18(2):362-82.
  355. Matsumoto T, Kawakami Y, Oana K, et al.  First isolation of Dysonomonas mossii from intestinal juice of a patient with pancreatic cancer.  Arch Med Res 2006;37(7):914-6.
  356. Matsuschek E, Ahman J, Kahlmeter G, et al. Antimicrobial susceptibility testing of Kingella kingae with broth microdilution and disk diffusion using EUCAST recommended media. Clin Microbiol Infect 2018;24:396-401.
  357. Maurissen W, Eyskens B, Gewillig M, et al. Beta-lactamase-positive Cardiobacterium hominis strain causing endocarditis in a pediatric patient with tetralogy of Fallot. Clin Microbiol Newsletter 2008;30(17):127-34.
  358. McHardy I, Veltman J, Hindler J, et al. Clinical and microbiological aspects of beta-lactam resistance in Staphylococcus lugdunensis. J Clin Microbiol 2017;55(2):585-95.
  359. McPherson C, Gal P, Ransom JL. Treatment of Citrobacter koseri infection with ciprofloxacin and cefotaxime in a preterm infant. Ann Pharmacother 2008;42(7):1134-8.
  360. Van der Mee-Marquet N, Achard A, Mereghetti L, et al.  Staphylococcus lugdunensis infections:  high frequency of inguinal area carriage.  J Clin Microbiol 2003;41(4):1404-9.
  361. Metzidie E, Manolis EN, Pournaras S, et al. Spread of an unusual penicillin- and imipenem-resistant but ampicillin-susceptible phenotype among Enterococcus faecalis clinical isolates. J Antimicrob Chemother 2006;57(1):158-60.
  362. Millan A, Escudero J, Gutierrez B, et al. Multiresistance in Pasteurella multocida is mediated by coexistence in small plasmids. Antimicrob Agents Chemother 2009;53(8):3399-404.
  363. Miller W, Seas C, Caravajal L, et al. The cefazolin inoculum effect is associated with increased mortality in methicillin-susceptible Staphylococcus aureus bacteremia. Open Forum Infect Dis 2018;5(6):1-9.
  364. Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM. Aminoglycosides: activity and resistance. Antimicrob Agents Chemother 1999;43(4):727-37.
  365. Mir-Cros A, Codina G, Martin-Gomez M, et al. Emergence of Bordetella holmesii as a causative agent of whooping cough, Barcelona, Spain. Emerg Infect Dis 2017;23(11):1856-9.
  366. Mnif B, Boujelbene I, Mahjoubi F, et al. Endocarditis due to Kytococcus schroeteri: case report and review of the literature. J Clin Microbiol 2006;44(3):1187-9.
  367. Mortensen JE, Giger O, Rodgers GL. In vitro activity of oral antimicrobial agents against clinical isolates of Pasteurella multocida. Diagn Microbiol Infect Dis 1998;30(2):99-102.
  368. Mory F, Fougnot F, Rabaud C, et al.  In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections.  J Antimicrob Chemother 2005;55:265-8.
  369. Moubareck C, Gavini F, Vaugien L, et al.  Antimicrobial susceptibility of Bifidobacteria.  J Antimicrob Chemother 2005;55(1):38-44.
  370. Mouton JW, van Ogtrop ML, Andes D, et al. Use of pharmacodynamic indices to predict efficacy of combination therapy in vivo. Antimicrob Agents Chemother 1999;43(10):2473-8.
  371. Mulvey MR, Grant JM, Plewes K, et al.  New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada.  Emerg Infect Dis 2011;17(1):103-6.
  372. Murphy TF, Parameswaran GI.  Moraxella catarrhalis, a human respiratory tract pathogen.  Clin Infect Dis 2009;49:124.
  373. Murray CK, Walter EA, Crawford S, et al. Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates. Clin Infect Dis 2001;32(10):E140-2.
  374. Muytjens HL, Eggink CA, Dijkman FCAP, et al.  Keratitis due to Shigella flexneri.  J Clin Microbiol 2006;44(6):2291-4.
  375. Na S, Park HJ, Park KH, et al. Enterococcus avium bacteremia: a 12-year clinical experience with 53 patients. Eur J Clin Microbiol Infect Dis 2012;31(3):303-10.
  376. Naas T, Aubert D, Oxcan A, et al. Chromosome-encoded narrow-spectrum ambler class A β-lactamase GIL-1 from Citrobacter gillenii. Antimicrob Agents Chemother 2007;51(4):1365-72.
  377. Nada B, Areej M. Raoultella planticola, a central venous line exit site infection. J T U Med Sci 2014;9(2):158-60.
  378. Nannini EC, Singh KV, Murray BE. Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue. Clin Infect Dis 2003;37(9):1194-8.
  379. Nannini E, Stryjewski M, Singh K, et al. Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure. Antimicrob Agents Chemother 2009;53(8):3437-41.
  380. Narchi H.  Kluyvera urinary tract infection case report and review of the literature.  Pediatric Infect Dis J 2005;24(6):570.
  381. Navas M, Hall G, Bejjani D. A case of endocarditis caused by Lactococcus garvieae and suggested methods for identification. J Clin Microbiol 2013;51(6):1990-2.
  382. Ndon JA.  Capnocytophaga canimorsus septicemia caused by a dog bite in a hairy cell leukemia patient.  J Clin Microbiol 1992;30(1):211-3.
  383. Neuwirth C, Siebor E, Duez JM, et al. Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins. J Antimicrob Chemother 1995;36(2):335-42.
  384. Nicolas P.  Emergence of non-ceftriaxone-susceptible Neisseria meningitidis in India.  J Clin Microbiol 2007;45(4):1378.
  385. Niyogi SK. Increasing antimicrobial resistance--an emerging problem in the treatment of shigellosis. Clin Microbiol Infect 2007;13(12):1141-3.
  386. Noonan L, et al.  Bacillus cereus and other non-anthracis Bacillus species.  UpToDate 2013.
  387. Norberg S, Stanton C, Ross R, et al. Cronobacter spp. in powdered infant formula. J Food Prot 2012;75(3)607-20.
  388. O’Connell K, Kelly J, NiRiain U, et al.  A rare case of soft-tissue infection caused by Raoultella planticola.  Case Reports in Medicine Volume 2010 (2010), Article ID 134086, 2 pages.
  389. Oikonomou K, Mcwilliams C, Moussa M. Oerskovia species bacteremia in a diabetic patient. J Glob Infect Dis 2018;10(2):113-4.
  390. Olsen DS, Asare K, Lyons M, et al.  A novel case of Raoultella planticola urinary tract infection.  Infection 2013;41(1):259-61.
  391. Oncel E, Ozsurekci Y, Akyon Y, et al. Kluyvera ascorbata infections in children: a case series. Turk Pediatri Ars 2015;50(2):123-8.
  392. Oprica C, Nord CE.  European surveillance study on the antibiotic susceptibility of Propionibacterium acnes.  Clin Microbiol Infect 2005;11:204-13.
  393. Orsborne C, Hardy A, Isalska B, et al. Acidovorax oryzae catheter-associated bloodstream infection. J Clin Microbiol 2014;52(12):4421-4.
  394. Otsuka Y, Kawamura Y, Koyama T, et al. Corynebacterium resistens sp. nov., a new multidrug-resistant coryneform bacterium isolated from human infections. J Clin Microbiol 2005;43(8):3713-7.
  395. Parha E, Alalade A, David K, et al. Brain abscess due to Trueperella bernardiae. Br J Neurosurg 2015;29(5):728-9.
  396. Paul M, Benuri-Silbiger I, Soares-Weiser K, et al. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 2004;328(7441):668.
  397. Peleg AY, Potoski BA, Rea R, et al.  Acinetobacter baumannii bloodstream infection while receiving tigecycline:  a cautionary report.  J Antimicrob Chemother 2007;59:128-31.
  398. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21(3):538-82.
  399. Perez-Vazquez M, et al.  Flouroquinolone resistance in Haemophilus influenzae is associated with hypermutability.  Antimicrob Agents Chemother 2007;51(4):1566-9.
  400. Pence M, Sharon J, Tekippe E, et al. Two cases of Kerstersia gyiorum isolated from sites of chronic infection. J Clin Microbiol 2013;51(6):2001-4.
  401. Pericas JM, Messina JA, Garcia-de-la-Maria C, et al. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal beta-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis. Clin Microbiol Infect 2017;23:544-9.
  402. Petti CA, Simmon KE, Miro JM, et al.  Genotypic diversity of coagulase-negative staphylococci causing endocarditis:  a global perspective.  J Clin Microbiol 2008;46:1780-4.
  403. Philippon A, Slama P, Deny P, et al. A structure-based classification of class A β-lactamases, a broadly diverse family of enzymes. Clin Microbiol Rev 2016;29(1):29-57.
  404. Ponce-Alonso M, Rodriguez-R, L, del Campo R, et al. Comparison of different methods for identification of species of the genus Raoultella: report of 11 cases of Raoultella causing bacteremia and literature review. Clin Micobiol Infect 2016;22:252-7.
  405. Poyart C, Pierre C, Quesne G, et al. Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob Agents Chemother 1997;41(1):24-9.
  406. Presterl E, Grisold AJ, Reichmann S, et al. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics. J Antimicrob Chemother 2005;55(1):45-50.
  407. Pritchard H. A case of pyelonephritis with bacteremia caused by Gardnerella vaginalis in a man. Infect Dis Clin Pract 2018;26(6):61-3.
  408. Proposal to remove macrolide breakpoints for Haemophilus influenzae but include a note on possible clinical efficacy and ECOFFs to distinguish wild type from isolates with acquired resistance. [internet] EUCAST. 2017 Oct. [cited 2019]. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Consultation/2017/Haem_and_macrolides/H_influenzae_macrolides_consultation_document_2017.pdf
  409. Proposed breakpoints for Aerococcus spp. and Kingella kingae. [internet] EUCAST 2016 [cited 2019]. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Consultation/2016/Aerococcus_and_Kingella_BP_consultation_and_responses_20161212.pdf
  410. Proposed introduction of oral amoxicillin breakpoints for Haemophillus influenzae and Streptococcus pneumoniae. [internet] EUCAST 2016 [cited 2019]. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Consultation/2018/Consultation_Amox_amp_Hi_Sp_oral_breakpoints_20180207.pdf
  411. Punpanich W, Srijuntongsiri S.  Pasteurella (Mannheimia) haemolytica septicemia in an infant:  a case report.  J Infect Dev Ctries 2012;67(7):584-7.
  412. Purty S, Saranathan R, Prashanth K, et al. The expanding spectrum of human infections caused by Kocuria species: a case report and literature review. Emerg Microbes Infect 2013;2(71):1-8.
  413. Quang VT. Susceptibility testing of Kingella kingae to cefazolin. Clin Microbiol Infect 2018;24:312-3.
  414. Radtke A, Bergh K, Oien C, et al. Peritoneal dialysis-associated peritonitis caused by Dermabacter hominis. J Clin Microbiol 2001;39(9):3420-1.
  415. Rahman S, Ali Tariq, Ali I, et al. The growing genetic and functional diversity of extended spectrum beta-lactamases. Biomed Res Int 2018;2018:1-14.
  416. Ramanan P, Deziel P, Wengenack N. Gordonia bacteremia. J Clin Microbiol 2013;51(10):3443-7.
  417. Ramana KV.  Kingella kingae a potentially emerging pathogen:  a comprehensive review.  Molecular Pathogens 2013;4(1):1-8.
  418. Ransom J, Carayannopoulos N. Cupriavidus pauculus osteomyelitis and secondary septic arthritis with hemodialysis origins: a case study. Transl Biomed 2016;7(4):95-8.
  419. Ratnayake L, Olver WJ, Fardon T.  Aggregatibacter aphrophilus in a patient with recurrent empyema:  a case report.  J Med Case Reports 2011;5:448.
  420. Raz R, Colodner R, Kunin CM.  Who are you – Staphylococcus saprophyticus?  Clin Infect Dis 2005;40:896-8.
  421. Reid KC, Cockerill IF, Patel R. Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases. Clin Infect Dis 2001;32(11):1540-6.
  422. Reid K, Rockerill R, Patel R. Clinical and epidemiological features on Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases. Clin Infect Dis 2001;32:1540-6.
  423. Reinhard M, Prag J, Kemp M, et al.  Ten cases of Actinobaculum schaalii infection:  clinical relevance, bacterial identification, and antibiotic susceptibility.  J Clin Microbiol  2005;43(10):5305-8.
  424. Renvoise A, Harle JR, Raoult D, et al.  Gordonia sputi bacteremia.  Centers for Disease Control and Prevention.  Letter Sept 2009;15(9).
  425. Renvoise A, Roux V, Casalta JP, et al. Kytococcus schroeteri, a rare agent of endocarditis. Int J Infect Dis 2008;12(2):223-7.
  426. Rhee C, Klompas M, Tamburini F, et al. Epidemiologic investigation of a cluster of neuroinvasive Bacillus cereus infections in 5 patients with acute myelogenous leukemia. Open forum Infect Dis 2015;2(3):1-7.
  427. Rhodes N, Gardiner B, Neely M, et al. Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis. J Antimicrob Chemother 2015;70:2068-73.
  428. Rimoldi S, Longhi E, Palazzin A, et al. Role of Chryseobacterium indologenes infection in a female with mediastinitis. Surg Infect Case Rep 2016;1(1):44-6.
  429. Rincon S, Reyes J, Carvajal L, et al. Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals. J Antimicrob Chemother 2013;68:2773-8.
  430. Risi GF, Spangler CA.  Capnocytophaga canimorsus meningitis after routine myelography:  a sentinel event identifies multiple opportunities for improvement of standard practices in radiology.  AJIC 2006;34(8):540-2.
  431. Roberts SA, Lang SDR. Achromobacter (Alcaligenes) species. Antimicrob Therapy Vaccines 1998 First Edition;1.
  432. Romano-Bertrand S, Bourdier A, Aujoulat F, et al. Skin microbiota is the main reservoir of Roseomonas mucosa, an emerging opportunistic pathogen so far assumed to be environmental. Clin Microbiol Infect 2016;22:737.e1-7.
  433. Romero B, Morosini MI, Loza E, et al.  Reidentification of Streptococus bovis isolates causing bacteremia according to the new taxonomy criteria:  still an issue?  J Clin Microbiol 2011;49(9):3228-33.
  434. Rosenau A, Labigne A, Escande F, et al. Plasmid-mediated ROB-1 β-lactamase in Pasteurella multocida from a human species. Antimicrob Agents Chemother 1991;35(11):2419-22.
  435. Ruiter N, Cnossen T, Bakker R, et al. Sphingobium olei peritonitis: peritoneal dialysis in turmoil? Perit Dial Int 2013;33(1):102-3.
  436. Ryan M, Adley C. The antibiotic susceptibility of water-based bacteria Ralstonia pickettii and Ralstonia insidiosa. J Clin Microbiol 2013;62:1025-31.
  437. Ryan M, Pembroke J. Brevundimonas spp: emerging global opportunistic pathogens. Virulence 2018;9(1):480-93.
  438. Ryoo NH,  Ha JS, Jeon DS, et al.  A case of pneumonia caused by Ewingella americana in a patient with chronic renal failure.  J Korean Med Sci 2005;20:143-5.
  439. Sabbe LJM, Van De Merwe D, Schouls L, et al.  Clinical spectrum of infections due to the newly described Actinomyces species A. turicensis, A. radingae, and A. europaeus.  J Clin Microbiol 1999; 37(1):8-13.
  440. Sack J, Peaper D, Mistry P, et al. Clinical implications of Paracoccus yeeii bacteremia in a patient with decompensated cirrhosis. ID Cases 2017;7:9-10.
  441. Sahbudak Bal Z, Sen S, Karapinar D, et al. The first reported catheter-related Brevibacterium casei bloodstream infection in a child with acute leukemia and review of the literature. Braz J Infect Dis 2015;19(2):213-5.
  442. Sader HS, Jones RN. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents 2005;25(2):95-109.
  443. Safdar N, Handelsman J, Maki DG. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 2004;4(8):519-27.
  444. Saito R, Okugawa S, Kumita W, et al. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients. Clin Microbiol Infect 2007;13(12):1204-6.
  445. Salas N, Prevost M, Hofinger D, et al. Cellulomonas, an emerging pathogen: a case report and review of the literature. Scand J Infect Dis Suppl 2014;46(1):73-5.
  446. Salminen MK, Rautelin H, Tynkkynen S, et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis 2004;38(1):62-9.
  447. Salminen MK, Rautelin H, Tynkkynen S, et al. Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis 2006;42(5):e35-44.
  448. Samarasekara H, Moxey S, Morrison K, et al. Case report of Erysipelothrix rhusiopathiae vertebral infection. Pathol 2018;50(1):117.
  449. Savini V, Catavitello C, Masciarelli G, et al.  Drug sensitivity and clinical impact of members of the genus Kocuria.  J Med Microbiol 2010;59:1395-1402.
  450. Schaefer G, Campbell W, Jenks J, et al. Persistent Bacillus cereus bacteremia in 3 persons who inject drugs, San Diego, California, USA. Emerg Infect Dis 2016;22(9):1621-3.
  451. Schett G, Herak P, Graninger W, et al.  Listeria-associated arthritis in a patient undergoing etanercept  therapy:  case report and review of the literature.  J Clin Microbiol  2005;43(5):2537-41.
  452. Schlaberg R, Huard RC, Della-Latta P, et al.  Nocardia cyriacigeorgica, an emerging pathogen in the United States.  J Clin Microbiol 2008;46(1):265-73.
  453. Seegmuller I, van der Linden M, Heeg C, et al.  Globicatella sanguinis is an etiological agent of ventriculoperitoneal shunt-associated meningitis.  J Clin Microbiol 2007;666-7.
  454. Seng P, Boushab M, Romain F, et al. Emerging role of Raoultella ornithinolytica in human infections: a series of cases and review of the literature. Int J Infect Dis 2016;45:65-71.
  455. Senn L, Entenza JM, Greub G,  et al.  Bloodstream and endovascular infections due to Abiotrophia defectiva and Granulicatella species.  BCM Infect Dis 2006;6:9.
  456. Shah N, Osmon DR, Fadel H, et al.  Laboratory and clinical characteristics of Staphylococcal lugdunensis prosthetic joint infections.  J Clin Microbiol 2010;48(5):1600-3.
  457. Sharifi-Rad M, Shadanpour S, Belkum A, et al. First case of vanA-positive Enterococcus mundtii in human urinary tract infection in Iran. New Microbes New Infect 2016;11:68-70.
  458. Sharma D, Patel A, Soni P, et al. Empedobacter brevis meningitis in a neonate: a very rare case of neonatal meningitis and literature review. Case Rep Pediatr 2016;2016:1-4.
  459. Sheikh-Taha M, Corman L. Pulmonary Nocardia beijingensis infection associated with the use of alemtuzumab in patients with multiple sclerosis. Mult Scler J 2017;23(6):872-4.
  460. Shukla SK, Paustian DL, Stockwell PJ, et al.  Isolation of a fastidious Bergeyella species associated with cellulitis after a cat bite and a phylogenetic comparison with Bergeyella zoohelcum strains.  J Clin Microbiol 2004;42(1):290-3.
  461. Sievert DM, Rudrik JT, Patel JB, et al.  Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.  Clin Infect Dis 2008;46:668-74.
  462. Simmons T, Fennelly E, Loughran D. Oligella ureolytica bacteremia in elderly women, United States. Emerg Infect Dis 2015;21(7):1271-3.
  463. Singhal N, Kumar M, Virdi J. Molecular analysis of β-lactamase genes to understand their differential expression in strains of Yersinia enterocolitica biotype 1A. Sci Rep 2014;4:5270.
  464. Skelton W, Taylor Z, Hsu J. ID Cases. 2017;8:9-11.
  465. Slenker AK, Hess BD, Jungkind DL, et al. Fatal case of Weeksella virosa sepsis.  J Clin Microbiol  2012;50:4166-7.
  466. Slinger R, Desjardins M, McCarthy AE, et al. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series. BMC Infect Dis 2004;4:36.
  467. Smego RA Jr., Foglia G. Actinomycosis. Clin Infect Dis 1998;26(6):1255-61.
  468. Smith AJ, Hall V, Thakker B, et al. Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents. J Antimicrob Chemother 2005;56(2):407-9.
  469. Soderquist Bo, Bjorklund S, Hellmark B, et al. Finegoldia magna isolated from orthopedic joint implant-associated infections. J Clin Microbiol 2017;55(11):3283-91.
  470. Song Y, Chengxu L, Finegold SM.  Peptoniphilus gorbachii sp. nov., Peptoniphilus olsenii sp. nov., and Anaerococcus murdochii sp. nov. isolated from clinical specimens of human origin.  J Clin Microbiol 2007;45(6):1746-52.
  471. Soriano F, Tauch A.  Microbiological and clinical features of Corynebacterium urealyticum:  urinary tract stones and genomics as the Rosetta Stone.  CMI 2008;14:632-43.
  472. Soriano F, Perez-Trallero E, Pallares R, et al. Streptococcus pneumoniae endophthalmitis: a study of 36 cases with special reference to antibiotic resistance and treatment options. Clin Microbiol Infect 2006;12(6):519-26.
  473. Spaniol V, Berhard S, Aebi C. Moraxella catarrhalis acrAB-OprM efflux pump contributes to antimicrobial resistance and is enhanced during cold shock response. Antimicrob Agents chemother 2015;59(4):1886-94.
  474. Spelman D.  Microbiology, epidemiology and pathogenesis of nocardiosis.  UpToDate 2012.
  475. Spiegel CA.  Susceptibility of Mobiluncus species to 23 antimicrobial agents and 15 other compounds.  Antimicrob Agents Chemother 1987;31(2):249-52.
  476. Steininger C, Willinger B. Resistance patterns in clinical isolates of pathogenic Actinomyces species. J Antimicrob Chemother 2016;71:422-7.
  477. Stenotrophomonas maltophilia [internet] EUCAST 2012 [cited 2019]. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/General_documents/S_maltophilia_EUCAST_guidance_note_20120201.pdf
  478. Stock I, Burak S, Sherwood K, et al. Natural antimicrobial susceptibilities of strains of ‘unusual’ Serratia species: S. ficaria, S. fonticola, S. odorifera, S. plymuthica, S. rubidaea. J Antimicrob Chemother 2003;51:865-85.
  479. Stock I, Burak S, Wiedemann B. Natural antimicrobial susceptibility patterns and biochemical profiles of Leclercia adecarboxylata strains. Clin Microbiol Infect 2004;10(8):724-33.
  480. Stock I, Wiedemann B. Natural antibiotic susceptibilities of Edwardsiella tarda, E. ictaluri and E. hoshinae. Antimicrob Agents Chemother.
  481. Stock I, Wiedemann B. Natural antibiotic susceptibility of Enterobacter amnigenus, Enterobacter cancerogenus, Enterobacter gergoviae and Enterobacter sakazakii strains. Clin Microbiol Infect 2002;8(9):564-78.
  482. Stock I. Plesiomonas shigelloides: an emerging pathogen with unusual properties. Reviews in Medical Microbiology 2004;15:129-39.
  483. Sturm PD, Van Eijk J, Veltman S, et al.  Urosepsis with Actinobaculum schaalii and Aerococcus urinae.  J Clin Microbiol 2006;44(2):652-4.
  484. Summa C, Walker S. Endocarditis due to Listeria monocytogenes in an academic teaching hospital: Can J Hosp Pharm. 2010;63(4):312-314.
  485. Sunnerhagen T, Hammarlund P, Rasmussen M. A case of suspected infective endocarditis with Lactococcus garvieae: lack of in vitro synergy between ampicillin and gentamicin. JMM Case Rep 2015;2(1):1-4.
  486. Swenson JM, Facklam RR, Thornsberry C. Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrob Agents Chemother 1990;34(4):543-9.
  487. Tafe LJ, Ruoff KL. Streptococcus bovis: answers and questions. Clin Microbiol Newsletter 2007;29(7):49-55.
  488. Talarmin J, Pineau S, Guillouzouic A, et al. Relapse of Enterococcus hirae prosthetic valve endocardidits. J Clin Microbiol 2011;49(3):1182-4.
  489. Tan C-K, Lai C-C, Lin S-H, et al. Fatal Citrobacter farmeri meningitis in a patient with nasopharyngeal cancer. J Clin Microbiol 2010;48(4):1499-1500.
  490. Taniyama D, Abe Y, Sakai T, et al. Human case of bacteremia caused by Streptococcus canis sequence type 9 harboring the scm gene. IDCases 2017;7:48-52.
  491. Tee WS, Soh SY, Lin R, et al. Staphylococcus lugdunensis carrying the mecA gene causes catheter-associated bloodstream infection in premature neonate. J Clin Microbiol 2003;41(1):519-20.
  492. Tena D, Ferdandez C, Lago M. Alcaligenes faecalis: an unusual cause of skin and soft tissue infection. Jpn J Infect 2015;68:128-30.
  493. Teng J, Dreyer L. Antimicrobial susceptibility patterns of anaerobic bacteria in Victoria, Australia. [Internet] 2018 Available from: https://www.biorxiv.org/content/10.1101/308023v1
  494. Teng J, Tang Y, Wong S, et al. MALDI-TOF MS for identification of Tsukamurella species: Tsukamurella tyrpsinosolvens as the predominant species associated with ocular infections. Emerging Microbes Infect 2018;7:80.
  495. Therriault BL, Daniels LM, Carter YL, et al.  Severe sepsis caused by Arcanobacterium haemolyticum:  a case report and review of the literature.  Ann Pharmacother  2008;42:1697.
  496. Tice AD, Hoaglund PA, Shoultz DA. Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemother 2003;51(5):1261-8.
  497. Tinguely R, Seiffert SN, Furrer H, et al.  Emergence of extensively drug-resistant Haemophilus parainfluenzae in Switzerland.  Antimicrob Agents Chemother 2013;57(6):2867-9.
  498. Toleman MA, Bennett PM, Bennett DM, et al. Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg Infect Dis 2007;13(4):559-65.
  499. Tomczak H, Bilska-Stoklosa J, Osmola K, et al.  Rothia mucilaginosa, rarely isolated pathogen as an etiological factor of infection of soft tissues in young, healthy women.  Postepy Hig Med Dosw (online) 2013;67:1-5.
  500. Topcu Y, Akinci G, Bayram E, et al.  Brain abscess caused by Lactococcus lactis cremoris in a child.  Eur J Pediatr 2011;170(12):1603-5.
  501. Treepong P, Kos VN, Guyeux C, et al. Global emergence of the widespread Pseudomonas aeruginosa ST235 clone. Clin Microbiol Infect 2018;24:258-66.
  502. Trinh S, Gavin H, Satchell K. Efficacy of ceftriaxone, cefepime, doxycycline, ciprofloxacin, and combination therapy for Vibrio vulnificus foodborne septicemia. Antimicrob Agents Chemother 2017;61(12):1-13.
  503. Tripodi MF, Fortunato R, Utili R, et al. Molecular epidemiology of Streptococcus bovis causing endocarditis and bacteraemia in Italian patients. Clin Microbiol Infect 2005;11(10):814-9.
  504. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 2007;20(2):368-89.
  505. Tsai CY, Su SH, Cheng YH, et al. Kocuria varians infection associated with brain abscess: a case report. BMC Infect dis 2010;10(102)1-4.
  506. Tsai MH, Huang YC, Chiu CH, et al. Nontyphoidal Salmonella bacteremia in previously healthy children: analysis of 199 episodes. Pediatr Inf Dis J 2007;26(10):909-13.
  507. Tsang R, Ahmad T, Jamieson F, et al. WGS analysis of a penicillin-resistant Neisseria meningitides strain containing a chromosomal ROB-1 β-lactamase gene. J Antimicrob Chemother 2019;74:22-8.

  508. Tugcu M, Ruhi C, Gokce Ali, et al. A case of urinary tract infection casued by Raoultella planticola after a urodynamic study. Braz J Infect Dis 2017;21(2):196-8.

  509. Van T, Naccache S, Bard J. The brief case: retropharyngeal abscess in a 14-year-old caused by Fusobacterium necrophorum. J Clin Microbiol 2018;56(12):1-5.

  510. Vanden Bempt I, Van Trappen S, Cleenwerck I, et al.  Actinobaculum schaalii Involved in Fournier’s gangrene.  J Clin Microbiol  2011;49(12):4311-3.
  511. Veloo ACM, Welling GW, Degener JE.  Antimicrobial susceptibility of clinically relevant Gram-positive anaerobic cocci collected over a three-year period in the Netherlands.  Antimicrobial Agents Chemother  2011;55(3):1199-203.
  512. Verma P, Brown JM, Nunez VH, et al.  Native valve endocarditis due to Gordonia polyisoprenivorans:  case report and review of literature of bloodstream infections caused by Gordonia species.  J Clin Microbiol 2006;44(5):1905-8.
  513. Versalovic J, editor in chief. Manual of Clinical Microbiology 10th Edition, Volume 1. Washington DC: ASM Press 2011.
  514. Veysseyre F, Fourcade C, Lavigne JP, et al. Bacillus cereus infection: 57 case patients and a literature review. Med Mal Infect 2015;(11-12):436-40.
  515. Villar HE, Danel F, Livermore DM. Permeability to carbapenems of Proteus mirabilis mutants selected for resistance to imipenem or other beta-lactams. J Antimicrob Chemother 1997;40(3):365-70.
  516. Vinh DC, Mubareka S, Fatoye B, et al.  Vibrio vulnificus septicemia after handling tilapia species fish:  a Canadian case report and review.  Can J Dis Med Microbiol 2006;17(2):129.
  517. von Eiff C, Herrmann M, Peters Gl.  Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp.  Antimicrob Agents Chemother 1995;39(1):268-70.
  518. Vossen M, Gattringer KB, Khalifeh N, et al.  Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha as acne inversa therapy.  J Clin Microbiol 2012;50(3):1109.
  519. Walckenaer E, Poirel L, Leflon-Guibout V, et al. Genetic and biochemical characterization of the chromosomal class A β-lactamases of Raoultella (formerly Klebsiella) planticola and Raoultella ornithinolytica. Antimicrob Agents Chemother 2004;48(1):305-12.
  520. Wallet F, Blondiaux N, Foy C, et al. Paracoccus yeei: a new unusual opportunistic bacterium in ambulatory peritoneal dialysis. Int J Infect Dis 2009;14:173-4.
  521. Walkty A.  Cardiobacterium hominis endocarditis:  a case report and review of the literature.  Can J Infect Dis Med Microbiol 2005;16(5):293
  522. Wang CY, Shie HS, Chen SC, et al. Lactococcus garvieae infections in humans:  possible association with aquaculture outbreaks.  Int J Clin Pract 2007;61(1):68-73.
  523. Wang J-L, Hsueh PR. Therapeutic options for infections due to vancomycin-resistant enterococci. Expert Opin Pharmacother 2009;10(5):785-96.
  524. Wang S, Gilchrist A, Loukitcheva A, et al. Prevalence of a cefazolin inoculum effect associated with blaZ gene types among methicillin-susceptible Staphylococcus aureus isolates from four major medical centers in Chicago. Antimicrob Agents Chemother 2018;62(8):1-5.
  525. Wankum M, Koutsari C, Gens K. Fosfomycin use. Pharm Times. [internet] 2017available from: https://www.pharmacytimes.com/publications/health-system-edition/2017/november2017/fosfomycin-use
  526. Weinbren MJ, Johnson AP, Kaufmann ME, et al. Acinetobacter spp. isolates with reduced susceptibilities to carbapenems in a UK burns unit. J Antimicrob Chemother 1998;41(5):574-6.
  527. Whatmore A, Engler K, Gudmundsdottir G, et al. Identification of isolates of Streptococcus canis infecting humans.  J Clin Microbiol 2001;39(1):4196-9.
  528. Wilson JW.  Nocardiosis:  updates and clinical overview.  Mayo Clin Proc 2012;87(4):403-7.
  529. Wong DW, Yang W, Vielemeyer O.  Catheter-related Leuconostoc bacteraemia in a pregnant HIV-infected woman.  J Med Cases 2012;3(6):331-3.
  530. Woo PCY, Tse H, Wong SSY, et al.  Life-threatening invasive Helcococcus kunzii infections in intravenous-drug users and ermA-mediated erythromycin resistance.  J Clin Microbiol 2005;3(12):6205.
  531. Wybo I, Pierard D, Verschraegen I, et al.  Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria.  J Antimicrob Chemother 2007;59:132-9.
  532. Wybo I, Van den Bossche D, Soetens O, et al.  Fourth Belgian Multicentre survey of antibiotic susceptibility of anaerobic bacteria.  J Antimicrob Chemother Advance Access Published Sept 5, 2013.
  533. Zheng X, Freeman AF, Villafranca J, et al. Antimicrobial susceptibilities of invasive pediatric Abiotrophia and Granulicatella isolates. J Clin Microbiol 2004;42(9):4323-6.
  534. Yagupsky P, Katz O, Peled N.  Antibiotic susceptibility of Kingella kingae isolates from respiratory carriers and patients with invasive infections.  J Antimicrob Chemother  2001;47:191-3.
  535. Yamshchikov A, Schuetz A, Lyon GM, et al.  Rhodococcus equi infection.  Lancet Infect Dis 2010;10:350-9.
  536. Yang K, Guglielmo BJ.  Diagnosis and treatment of extended-spectrum and AmpC β-lactamase-producing organisms.  Ann Pharmacother 2007;41:1427-35.
  537. Yarbough M, Hamad Y, Burnham C, et al. The brief case: bacteremia and vertebral osteomyelitis due to Staphylococcus schleiferi. J Clin Microbiol 2017;55(11):3157-3310.
  538. Yarbough M, Lainhart W, Burnham CA. Epidemiology, clinical characteristics, and antimicrobial susceptibility profiles of human clinical isolates of Staphylococcus intermedius group. J Clin Microbiol 2018;56(3):1-10.
  539. Yildiz O, Alp E, Tokgoz B, et al.  Nocardiosis in a teaching hospital in the Central Anatolia region of Turkey:  treatment and outcome.  Clin Microbiol Infect 2005;11(6):495-9.
  540. Yokota S, Ohkoshi Y, Sato K, et al.  Emergence of fluoroquinolone-resistant Haemophilus influenzae strains among elderly patients but not among children.  J Clin Microbiol 2008;46(1):361-5.
  541. Young N, Bhally H. Bilateral neck pyomyositis caused by Staphylococcus capitis and Staphylococcus saccharolyticus in a diabetic adult. Case Rep Infect Dis 2017:1-3.
  542. Zapun A, Morlot C, Taha M-K. Resistance to β-lactams in Neisseria spp due to chromosomally encoded penicillin-binding proteins. Antibiotics 2016;5(4);1-12.
  543. Zhang F, Fang Y, Pang F, et al. Rare Shewanella spp associated with pulmonary and bloodstream infections of cancer patients, China: a case report. BMC Infect Dis 2018;18:1-5.
  544. Zhao WH, Hu ZQ. Acinetobacter: a potential reservoir and dispenser for beta-lactamases. Clin Rev Microbiol 2011;38(1):30-51.
  545. Zheng B, Zhang J, Ji J, et al. Emergence of Raoultella ornithinolytica coproducing IMP-4 and KPC-2 carbapenemases in China. Antimicrob Agents Chemother 2015;59(11):7086-9.
  546. Zuberbuhler B, Abedin A, Roudsari A, et al.  A novel case of chronic conjunctivitis in a 58-year-old woman caused by Raoultella infection.  Infection 2014;42(5):927-9.

Commensal and Pathogenic Organisms for Specific Body Sites

  1. Isenberg HD, D’Amato RF.  Indigenous and pathogenic microorganisms of humans.   In: Murray PR, Baron EJ, Pfaller MA, et al, eds.  Manual of clinical microbiology.  6th ed. American Society of Microbiology 1995:5-18.
  2. Koneman EW, Allen SD, Janda WM, et al.  Color atlas and textbook of diagnostic microbiology.  5th ed. Philadelphia: J.B. Lippincott Company 1997.